Company / Current Liabilities
Vir Biotechnology, Inc. Current Liabilities History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$92.8M
FY2025
5-year range
$92.8M / $511.0M
FY2021-FY2025
Trend
-22.4%
vs FY2024
Sector context
#102 of 213
Health Care
What the data says
At $93M, Vir Biotechnology, Inc.'s current liabilities ranks #112 of 213 in the Health Care sector. Current Liabilities has declined for 3 consecutive years, from $511M in FY2022 to $93M in FY2025.
Based on SEC 10-K filings.
$93M in FY2025 with a 5-year CAGR of -1.3%.
Improved from $175M to $93M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -43.4%
- 5-Year CAGR
- -1.3%
- 10-Year CAGR
- -
Sector benchmark
#112 of 213 in Health CareTop 52% of 213This company $92.8M Sector average $1.6B
▼
-94.2% below sector average
Key checks
Key Insights
- Vir Biotechnology, Inc.'s current liabilities has declined for 3 consecutive years.
- 5-year CAGR of -1.3%, indicating a declining trend.
- In FY2025, current liabilities decreased 22.4% year-over-year.
- Ranks #102 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $92.8M | -22.4% |
| FY2024 | $119.7M | -31.8% |
| FY2023 | $175.4M | -65.7% |
| FY2022 | $511.0M | +49.8% |
| FY2021 | $341.2M | +244.5% |
| FY2020 | $99.1M | +67.3% |
| FY2019 | $59.2M | +48.4% |
| FY2018 | $39.9M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026